Connective Tissue Diseases Clinical Trials

13 recruiting

Connective Tissue Diseases Trials at a Glance

17 actively recruiting trials for connective tissue diseases are listed on ClinicalTrialsFinder across 6 cities in 17 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Tianjin, Jinan, and Bordeaux. Lead sponsors running connective tissue diseases studies include Beijing Hospital, CHU de Quebec-Universite Laval, and Bastiaan Driehuys.

Browse connective tissue diseases trials by phase

Treatments under study

About Connective Tissue Diseases Clinical Trials

Looking for clinical trials for Connective Tissue Diseases? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Connective Tissue Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Connective Tissue Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 117 of 17 trials

Recruiting
Not Applicable

Early Recognition of Progressive Lung Fibrosis in Systemic Rheumatic Diseases

Interstitial Lung DiseaseConnective Tissue Diseases
Fondazione Policlinico Universitario Agostino Gemelli IRCCS200 enrolled1 locationNCT07541638
Recruiting
Not Applicable

Impact of Capillaroscopy in the Investigation of Diffuse Interstitial Pneumonias

Interstitial Lung DiseaseConnective Tissue Diseases
University Hospital, Bordeaux48 enrolled1 locationNCT07283081
Recruiting
Not Applicable

Impact of Capillaroscopy on the Management of Undifferentiated Connective Tissue Disease

Undifferentiated Connective Tissue Diseases
CHU de Quebec-Universite Laval40 enrolled1 locationNCT06399822
Recruiting
Phase 2

129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial HypertensionConnective Tissue DiseasesIdiopathic Pulmonary Arterial Hypertension+1 more
Bastiaan Driehuys20 enrolled1 locationNCT06104228
Recruiting

Rheumatology Patient Registry and Biorepository

Rheumatoid ArthritisLyme DiseaseSarcoidosis+17 more
Yale University5,000 enrolled1 locationNCT04402086
Recruiting
Phase 3

A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

Connective Tissue Diseases
GlaxoSmithKline514 enrolled10 locationsNCT06716606
Recruiting
Not Applicable

Clinical Study on the Safety and Efficacy of CD19-BCMA CAR-T Cell Therapy for Connective Tissue Diseases

Connective Tissue Diseases
Guangzhou Bio-gene Technology Co., Ltd20 enrolled1 locationNCT07152223
Recruiting
Phase 2

Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia

ThrombocytopeniaConnective Tissue Diseases
Beijing Hospital296 enrolled23 locationsNCT05998759
Recruiting
Phase 2

Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

Connective Tissue DiseasesImmune ThrombocytopeniaEvan Syndrome+1 more
Institute of Hematology & Blood Diseases Hospital, China52 enrolled1 locationNCT04993885
Recruiting
Not Applicable

RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myosteatosis and NMJ Degeneration

SarcopeniaMusculoskeletal AbnormalitiesConnective Tissue Diseases in Old Age
Chinese University of Hong Kong200 enrolled3 locationsNCT05525039
Recruiting
Not Applicable

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

Rheumatoid ArthritisConnective Tissue DiseasesDermatomyositis+3 more
Oslo University Hospital218 enrolled1 locationNCT06732674
Recruiting
Phase 4

Treatment Effects of Two Pharmaceutical Skin Care Creams for Xerotic Feet Among Persons with Diabetes

Diabetes MellitusSkin and Connective Tissue Diseases
Malmö University98 enrolled1 locationNCT06427889
Recruiting

Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland

Interstitial Lung DiseasePulmonary FibrosisIdiopathic Pulmonary Fibrosis+3 more
Royal College of Surgeons, Ireland300 enrolled1 locationNCT06702228
Recruiting
Phase 1Phase 2

ADSCs Therapy in Patients With CTD-ILD

Interstitial Lung DiseaseConnective Tissue Diseases
China Medical University Hospital16 enrolled1 locationNCT06574581
Recruiting

The Clinical Features and Pregnancy Outcomes of CTD Patients

Connective Tissue DiseasesPregnancy Related
Qilu Hospital of Shandong University126 enrolled1 locationNCT04918524
Recruiting

REgistry of Pulmonary Arterial Hypertension Associated With CONNECTIVE Tissue Diseases (RECONNECTIVE)

Pulmonary Arterial HypertensionConnective Tissue Diseases
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran170 enrolled1 locationNCT05665556
Recruiting

Connective Tissue Diseases and Lung Manifestations

Interstitial Lung DiseaseConnective Tissue DiseasesSystemic Sclerosis
Medical University Innsbruck120 enrolled1 locationNCT04095351